Purple Biotech PPBT 深 沪
等待开盘 10-04 09:30:00 美东时间
0.5938
+0.023
+4.05%
华盛通- 最 高0.5938
- 今 开0.59
- 成交量 13.87万股
- 最 低 0.5711
- 昨 收 0.5707
- 总市值 157.25万
- 52周最高 13.95
- 市盈率 静 --
- 换手率 5.24%
- 52周最低 0.5326
- 委 比 61.29%
- 总股本 264.82万
- 历史最高 1390.00
- 量 比 0.57
- 振 幅 3.98%
- 历史最低 0.5326
- 每 手 1
- 风险率 1.07%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Purple Biotech Enters New ATM Agreement with H.C. Wainwright
The latest announcement is out from Purple Biotech ( ($PPBT) ). On September 19...
09-20 05:39
Purple Biotech Secures European Patent for NT219 Combinations
An update from Purple Biotech ( ($PPBT) ) is now available. On September 10, 20...
09-10 20:28
Purple Biotech Receives Intention to Grant a European Patent Covering NT219 Combinations with Immunotherapies or MEK Inhibitors to Overcome Tumor Resistance
Purple Biotech Ltd. announced that the European Patent Office has issued an intention to grant a patent for their application on combining NT219 with immunotherapies and other anti-cancer agents. The patent, if granted, will provide protection for NT219 combinations designed to enhance cancer treatment efficacy, particularly in resistant cancers. NT219 targets IRS1/2 and STAT3, key drivers of drug resistance and tumor immune evasion. The company ...
09-10 12:00
Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
Purple Biotech Ltd. 宣布完成5,999,999股美国存托股票（ADS）的公开发行，总金额约600万美元，并附带可额外筹集1200万美元的短期认股权证。资金将用于癌症治疗候选药物的开发及一般运营。
09-05 20:00
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Bone Biologics (NASDAQ:BBLG) stock moved upwards by 38.2% to $2.86 dur...
09-05 01:05
Purple Biotech Announces Pricing of Up To $18 Million Public Offering
Purple Biotech Ltd. announced a public offering of 5,999,999 ADSs and short-term warrants to purchase up to 11,999,998 ADSs at $1.00 per share, with upfront gross proceeds of $6 million and potential additional $12 million upon warrant exercise. The funds will support oncology therapeutic development and general corporate purposes. The offering is underwritten by H.C. Wainwright & Co. and includes candidates CAPTN-3, IM1240, and CM24 targeting tu...
09-04 13:15
Purple Biotech Announces New Data Supporting the Unique Design of CAPTN-3 Tri-Specific Antibody IM1240 in Collaboration with the Icahn School of Medicine at Mount Sinai
Purple Biotech announced new data on its CAPTN-3 tri-specific antibody IM1240, targeting 5T4, a tumor-associated antigen. IM1240 demonstrated tumor cell death in treatment-resistant head and neck cancer biopsies, with synergistic effects between its NK and T cell engager arms. Analysis of human transcriptomes supports the design, showing NKG2A expression consistently accompanies 5T4 in solid tissues. IM1240 is advancing toward first-in-human clin...
09-04 11:00
Purple Biotech Announced Its Second CAPTN-3 Trispecific Antibody, IM1305, Targeting TROP2 In Development, FDA Investigational New Drug Submission Planned For 2026
IM1305 (capped-CD3xTROP2xNKG2A) contains a masked anti-CD3 arm, as well as an anti-NKG2A arm, and an anti-TROP2 arm. The potent anti-CD3 arm is masked at the periphery with a cleavable cap, designed to be removed
09-03 19:14
Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Purple Biotech Ltd. (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies to address tumor immune evasion and drug resistance, announced that CEO Gil Efron will participate in a fireside chat and 1x1 investor meetings at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025. The fireside chat will take place on September 10, 2025, at 11:30 AM ET. The Company’s oncology pipeline includes C...
08-27 11:00
Purple Biotech GAAP EPADS of -$0.57
Purple Biotech press release (NASDAQ:PPBT): Q2 GAAP EPADS of -$0.57. As of June 30, 2025, Purple Biotech had cash and cash equivalents and short-term deposits of $5.6 million. The Company cash runway ...
08-06 19:44
